Diagnostic News and Research

RSS

Diagnosis of viral infections using micro and nanoscale technologies

In a recent study, the authors provide a review on both micro- and nanoscale technologies that advanced the diagnosis of viral diseases.

3 Aug 2021

Study examines efficacy Pfizer-BioNTech vaccine among USAF Academy Cadets

A new study published on the medRxiv* preprint server has estimated the effectiveness of vaccines in preventing COVID-19 as a function of time since vaccination.

3 Aug 2021

Analysis reveals positive association between high-sensitivity C-reactive protein and odds of breast cancer

Oncotarget published "Association of high-sensitivity C-reactive protein and odds of breast cancer by molecular subtype: analysis of the MEND study" which reported that the authors examined the association of high-sensitivity CRP with odds of BC by molecular subtype among Nigerian women.

2 Aug 2021

Study examined 1,497 full-vaccinated healthcare workers for breakthrough infections

A new study published in The New England Journal of Medicine found that in a very small number of cases, people with breakthrough infections might suffer long-lasting COVID-19 symptoms.

2 Aug 2021

New integrative NGS panel for analysis of standard and novel biomarkers in lymphoid neoplasms

Increasing knowledge about genomic biomarkers has facilitated better monitoring and personalized management of patients with B-cell malignant tumors.

29 Jul 2021

New tool could transform the management of cardiac sarcoidosis patients

Johns Hopkins University scientists have developed a new tool for predicting which patients suffering from a complex inflammatory heart disease are at risk of sudden cardiac arrest.

28 Jul 2021

Scientists identify an antiviral metabolite as a potential serum biomarker for SARS-CoV-2 infection

Scientists from the UK have recently identified an antiviral metabolite 3'-Deoxy-3',4'-didehydro-cytidine as a potential serum biomarker to diagnose active severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection. The study is currently available on the medRxiv* preprint server while awaiting peer review.

27 Jul 2021

Study could lead to blood-based diagnostic test for schizophrenia

Scientists at Sanford Burnham Prebys have discovered how levels of a protein could be used in the future as a blood-based diagnostic aid for schizophrenia.

27 Jul 2021

Experts present new research to improve care for head and neck cancers at AHNS 2021

As the international community of experts in head-and-neck cancers gathered virtually last week to share new ideas and treatment strategies at the just-ended American Head & Neck Society (AHNS) 10th International Conference on Head and Neck Cancer, Roswell Park Comprehensive Cancer Center teams are presented new research on both the basic science supporting new treatments as well as opportunities to improve the early and accurate diagnosis of thyroid cancer and other head/neck malignancies.

26 Jul 2021

MUSC Hollings Cancer Center part of promising phase 2 lymphoma clinical trial

MUSC Hollings Cancer Center was one of 28 clinical sites around the world that participated in the LOTIS-2 trial to test the efficacy of Loncastuximab tesirine, a promising new treatment for aggressive B-cell lymphoma.

23 Jul 2021

Clinical trials during a pandemic – lessons from COVID-19

In this interview, Dr. Benedicte Roquebert, Dr. Stephanie Haim-Boukobza and Dr. Souad Mehlal discuss how COVID-19 has resulted in new ways to think about clinical trials during a pandemic.

From Cerba Research 23 Jul 2021

New blood test could help predict the severity of COVID-19 symptoms

During the height of the pandemic, some hospitals were overwhelmed with patients seeking treatment for COVID-19.

22 Jul 2021

Virginia Tech's in-house development of novel SARS-CoV-2 test shows the power of academic labs

In the early days of the pandemic, scientists at Virginia Tech created a COVID-19 testing laboratory and novel test for the virus from scratch.

21 Jul 2021

MET amplification identified as a potentially actionable driver for non-small cell lung cancer

A study led by D. Ross Camidge, MD, PhD, director of thoracic oncology at the University of Colorado School of Medicine and CU Cancer Center member, has helped to define MET amplification as a rare but potentially actionable driver for non-small cell lung cancer (NSCLC).

20 Jul 2021

Owlstone Medical publishes data on the use of face mask filters to capture viral particles for SARS-CoV-2 detection

Owlstone Medical today announced the publication of a peer-reviewed study in Nature Scientific Reports.

From Owlstone Medical Ltd 20 Jul 2021

Same-day screening and health education program seeks to reduce disparities of preventable cancers

Evidence shows that early detection and treatment of cancer can significantly improve health outcomes, however women in Mississippi, particularly in underserved populations, experience the worst health outcomes for cervical, breast, and oropharyngeal cancer.

20 Jul 2021

UniSA professor calls for parents to check child's sleep before switching off

The struggle to get your child to go to sleep and stay asleep is something most parents can relate to. Once the bedtime battle is over and the kids have finally nodded off, many parents tune out as well.

19 Jul 2021

Study illuminates an invisible crisis in children’s mental health

One in eight children have mental disorders that cause symptoms and impairment and therefore require treatment, but even in high-income countries most of these children will not gain access to services to treat them, reports a study published in the journal Evidence-Based Mental Health.

19 Jul 2021

Researchers isolate human monoclonal antibodies that may neutralize several norovirus variants

Researchers at Vanderbilt University Medical Center and the Baylor College of Medicine in Houston, Texas, have taken a big step toward developing targeted treatments and vaccines against a family of viruses that attacks the gastrointestinal tract.

16 Jul 2021

Psychiatric patients have higher odds of hospitalization and death following COVID-19

In the largest systematic review and meta-analysis to date on COVID-19 outcomes in individuals with psychiatric disorders, the odds of dying or being hospitalized following COVID-19 infection were determined to be twice as high in comparison to persons without mental disorders.

16 Jul 2021

Diagnostic News and Research

Diagnosis of viral infections using micro and nanoscale technologies

Study examines efficacy Pfizer-BioNTech vaccine among USAF Academy Cadets

Analysis reveals positive association between high-sensitivity C-reactive protein and odds of breast cancer

Study examined 1,497 full-vaccinated healthcare workers for breakthrough infections

New integrative NGS panel for analysis of standard and novel biomarkers in lymphoid neoplasms

New tool could transform the management of cardiac sarcoidosis patients

Scientists identify an antiviral metabolite as a potential serum biomarker for SARS-CoV-2 infection

Study could lead to blood-based diagnostic test for schizophrenia

Experts present new research to improve care for head and neck cancers at AHNS 2021

MUSC Hollings Cancer Center part of promising phase 2 lymphoma clinical trial

Clinical trials during a pandemic – lessons from COVID-19

New blood test could help predict the severity of COVID-19 symptoms

Virginia Tech's in-house development of novel SARS-CoV-2 test shows the power of academic labs

MET amplification identified as a potentially actionable driver for non-small cell lung cancer

Owlstone Medical publishes data on the use of face mask filters to capture viral particles for SARS-CoV-2 detection

Same-day screening and health education program seeks to reduce disparities of preventable cancers

UniSA professor calls for parents to check child's sleep before switching off

Study illuminates an invisible crisis in children’s mental health

Researchers isolate human monoclonal antibodies that may neutralize several norovirus variants

Psychiatric patients have higher odds of hospitalization and death following COVID-19

Bringing real-time analytics to downstream bioprocess monitoring

Designing fluidic architecture for scalable diagnostic platforms

Evaluating new approaches for rare disease genomics

Latest News